Correlation Between DexCom and Fulgent Genetics
Can any of the company-specific risk be diversified away by investing in both DexCom and Fulgent Genetics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DexCom and Fulgent Genetics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DexCom Inc and Fulgent Genetics, you can compare the effects of market volatilities on DexCom and Fulgent Genetics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DexCom with a short position of Fulgent Genetics. Check out your portfolio center. Please also check ongoing floating volatility patterns of DexCom and Fulgent Genetics.
Diversification Opportunities for DexCom and Fulgent Genetics
-0.72 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between DexCom and Fulgent is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding DexCom Inc and Fulgent Genetics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fulgent Genetics and DexCom is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DexCom Inc are associated (or correlated) with Fulgent Genetics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fulgent Genetics has no effect on the direction of DexCom i.e., DexCom and Fulgent Genetics go up and down completely randomly.
Pair Corralation between DexCom and Fulgent Genetics
Given the investment horizon of 90 days DexCom Inc is expected to generate 0.97 times more return on investment than Fulgent Genetics. However, DexCom Inc is 1.03 times less risky than Fulgent Genetics. It trades about 0.1 of its potential returns per unit of risk. Fulgent Genetics is currently generating about -0.13 per unit of risk. If you would invest 12,196 in DexCom Inc on January 26, 2024 and sell it today you would earn a total of 1,591 from holding DexCom Inc or generate 13.05% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
DexCom Inc vs. Fulgent Genetics
Performance |
| Timeline |
| DexCom Inc |
| Fulgent Genetics |
DexCom and Fulgent Genetics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with DexCom and Fulgent Genetics
The main advantage of trading using opposite DexCom and Fulgent Genetics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DexCom position performs unexpectedly, Fulgent Genetics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fulgent Genetics will offset losses from the drop in Fulgent Genetics' long position.The idea behind DexCom Inc and Fulgent Genetics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Fulgent Genetics vs. Aclaris Therapeutics | Fulgent Genetics vs. Prenetics Global | Fulgent Genetics vs. DarioHealth Corp | Fulgent Genetics vs. Olink Holding AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |